The Complex Clinical Picture of β-Lactam Hypersensitivity: Penicillins, Cephalosporins, Monobactams, Carbapenems, and Clavams

Medical Clinics of North America

Volumn 94, Issue 4, 2010, Pages 805-820

  Torres, Maria J ^a   Blanca, Miguel ^a  

^a Allergy Service   (Spain)

Author keywords

Lactam; Drug provocation test; Management; Skin test

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM; CARBAPENEM; CEPHALOSPORIN; CLAVAM; CLAVULANIC ACID; HAPTEN; MONOBACTAM; PENICILLIN G; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DESENSITIZATION; DIAGNOSTIC PROCEDURE; DRUG HYPERSENSITIVITY; DRUG PROVOCATION TEST; DRUG STRUCTURE; HEMATOLOGICAL PARAMETERS; HUMAN; IN VITRO STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SKIN TEST;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CARBAPENEMS; CEPHALOSPORINS; CLAVULANIC ACIDS; CROSS REACTIONS; DRUG HYPERSENSITIVITY; HUMANS; MONOBACTAMS; PENICILLINS; RISK FACTORS; SKIN TESTS;

EID: 77953673958     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.04.006     Document Type: Review

References (79)

1. Blanca M. Allergic reactions to penicillins. A changing world?. Allergy 50 (1995) 777-782
2. Torres M.J., Ariza A., Mayorga C., et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol 125 (2010) 502-505
3. Coombs P.R., and Gell P.G. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell R.R. (Ed). Clinical aspects of immunology (1968), Oxford University Pess, Oxford (UK) 575-596
4. Levine B. Immunological mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases in man. N Engl J Med 275 (1966) 1115-1125
5. Weiss M.E., and Adkinson N.F. Immediate hypersensitivity reactions to penicillin and related antibotics. Clin Allergy 18 (1988) 515-540
6. Ahlstedt S. Penicillin allergy. Can the incidence be reduced?. Allergy 39 (1984) 151-164
7. Rebelo-Gomes E., and Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 5 (2005) 309-316
8. Idsoe O., Guthe T., Wilcox R.R., et al. Nature and extent of penicillin side reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ 38 (1968) 159-188
9. Gadde J., Spence M., Wheeler B., et al. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA 27 (1993) 2456-2463
10. Blanca M., Vega J.M., García J., et al. New aspects of allergic reactions to betalactams. Cross-reactions and unique specificities. Clin Exp Allergy 24 (1994) 407-415
11. Torres M.J., Mayorga C., Pamies R., et al. Immunologic response to different determinants of benzylpenicillin, amoxicillin, and ampicillin. Comparison between urticaria and anaphylactic shock. Allergy 54 (1999) 936-943
12. Padial A., Antunez C., Blanca-Lopez N., et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 38 (2008) 822-828
13. Blanca-Lopez N., Zapatero L., Alonso E., et al. Skin testing and drug provocation tests in the diagnosis of non immediate reactions to aminopenicillins in children. Allergy 64 (2009) 229-233
14. Warrington R.J., Silviu-Dan F., and Magro C. Accelerated cell-mediated immune reactions in penicillin allergy. J Allergy Clin Immunol 92 (1993) 626-628
15. Mayorga C., Torres M.J., Fernandez J., et al. Cutaneous symptoms in drug allergy: what have we learnt?. Curr Opin Allergy Clin Immunol 9 (2009) 431-436
16. Romano A., Di Fonso M., Papa G., et al. Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes. Allergy 50 (1995) 113-118
17. Terrados S., Blanca M., Garcia J., et al. Non-immediate reactions to betalactams: prevalence and role of the different penicillins. Allergy 50 (1995) 563-567
18. Doña I., Chaves P., Gómez E., et al. Drug rash with eosinophilia and systemic symptoms after penicillin V administration in a patient with acquired C1 inhibitor acquired deficiency. J Investig Allergol Clin Immunol 19 (2009) 325-327
19. Liberopoulos E.N., Liamis G.L., and Elisaf M.S. Possible cefotaxime-induced Stevens-Johnson syndrome. Ann Pharmacother 37 (2003) 812-814
20. Saenz de San Pedro Morera B., Enriquez J.Q., and López J.F. Fixed drug eruptions due to betalactams and other chemically unrelated antibiotics. Contact Dermatitis 40 (1999) 220-221
21. Clark B.M., Kotti G.H., Shah A.D., et al. Severe serum sickness reaction to oral and intramuscular penicillin. Pharmacotherapy 26 (2006) 705-708
22. Arndt P.A. Practical aspects of investigating drug-induced immune haemolytic anemia due to cefotetan or ceftriaxone-a case study approach. Immunohematology 18 (2002) 27-32
23. Leger R.M., Arndt P.A., and Garratty G. Serological studies of piperacillin antibodies. Transfusion 48 (2008) 2429-2434
24. Arndt P.A., and Garratty G. The changing spectrum of drug-induced immune hemolytic anemia. Semin Hematol 42 (2005) 137-144
25. Olaison L., Belin L., Hogevik H., et al. Incidence of beta-lactam-induced delayed hypersensitivity and neutropenia during treatment of infective endocarditis. Arch Intern Med 159 (1999) 607-615
26. Gielen K., and Goosens A. Occupational allergic contact dermatitis from drug healthy healthcare workers. Contact Dermatitis 45 (2001) 273-279
27. Stricker B.H., Van den Broek J.W., Keuning J., et al. Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (augmentin). Dig Dis Sci 34 (1989) 1576-1580
28. Andrews E., and Daly A.K. Flucloxacillin-induced liver injury. Toxicology 254 (2008) 158-163
29. Castell J.V., and Castell M. Allergic hepatitis induced by drugs. Curr Opin Allergy Clin Immunol 6 (2006) 258-265
30. Gresser U. Amoxicillin-clavulanic acid therapy may be associated with severe side effects-review of the literature. Eur J Med Res 6 (2001) 139-149
31. Daly A.K., Donaldson P.T., Bhatnagar P., et al. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 41 (2009) 816-819
32. Spanou Z., Keller M., Britschgi M., et al. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. J Am Soc Nephrol 17 (2006) 2919-2927
33. Sammett D., Greben C., and Sayeed-Shah U. Acute pancreatitis caused by penicillin. Dig Dis Sci 43 (1998) 1778-1783
34. Yonemaru M., Mizuguchi Y., Kasuga I., et al. Hilar and mediastinal lymphadenopathy with hypersensitivity pneumonitis induced by penicillin. Chest 102 (1992) 1907-1909
35. Burke A.P., Saenger J., Mullick F., et al. Hypersensitivity myocarditis. Arch Pathol Lab Med 115 (1991) 764-769
36. Levine B.B., and Ovary Z. Studies of the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G. J Exp Med 114 (1961) 875-904
37. Dewdney J.M. Immunology of the antibiotics. In: Sela M. (Ed). The antigens vol. 4 (1977), Academic Press, New York 114-122
38. Warbrick E.V., Thomas A.L., Stejkal V., et al. An analysis of betalactam derived antigens on spleen cells and serum proteins by ELISA and Western blotting. Allergy 50 (1995) 910-917
39. Adkinson Jr. N.F., Thompson W.L., Maddrey W.C., et al. Routine use of penicillin skin testing on an inpatient service. N Engl J Med 285 (1971) 22-24
40. Parker C.W., de Weck A.L., Shapiro J., et al. The preparation and some properties of penicillenic acid derivatives relevant to penicillin hypersensitivity. J Exp Med 115 (1962) 803-819
41. Levine B.B., and Redmond A.P. Minor haptenic determinant specific reagins of penicillin hypersensitivity in man. Int Arch Allergy Appl Immunol 35 (1969) 445-455
42. Perez-Inestrosa E., Suau R., Montañez M.I., et al. Cephalosporin chemical reactivity and its immunological implications. Curr Opin Allergy Clin Immunol 5 (2005) 323-330
43. Romano A., Mayorga C., Torres M.J., et al. Immediate allergic reactions to cephalosporins: cross-reactivity and selective responses. J Allergy Clin Immunol 106 (2000) 1177-1183
44. Antúnez C., Blanca-López N., Torres M.J., et al. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol 117 (2006) 404-410
45. De Haan P., Jonge A.J., Verbrugge E., et al. Three epitope-specific monoclonal antibodies against the hapten penicillin. Int Arch Allergy Appl Immunol 76 (1985) 42-46
46. Mayorga C., Obispo T., Jimeno L., et al. Epitope mapping of betalactam antibiotics with the use of monoclonal antibodies. Toxicology 97 (1995) 225-234
47. Nagakura N., Souma S., Shimizu T., et al. Antiampicillin monoclonal antibodies and their cross-reactivities to various ß-lactams. J Antimicrob Chemother 28 (1991) 357-368
48. Nagakura N., Shimizu T., Masuzawa T., et al. Anti-cephalexin monoclonal antibodies and their cross-reactivities to cephems and penams. Int Arch Allergy Appl Immunol 93 (1990) 126-132
49. Shimizu T., Souma S., Nagakura N., et al. Epitope analysis of aztreonam by antiaztreonam monoclonal antibodies and possible consequences in beta-lactams hypersensitivity. Int Arch Allergy Immunol 98 (1992) 392-397
50. Moreno F., Blanca M., Mayorga C., et al. Studies of the specificities of IgE antibodies found in sera from subjects with allergic reactions to penicillins. Int Arch Allergy Appl Immunol 108 (1995) 74-81
51. Blanca M., Garcia J., Vega J.M., et al. Anaphylaxis to penicillins after non-therapeutic exposure: an immunological investigation. Clin Exp Allergy 26 (1996) 335-340
52. Co Minh H.B., Bousquet P.J., Fontaine C., et al. Systemic reactions during skin tests with betalactams: a risk factor analysis. J Allergy Clin Immunol 117 (2006) 466-468
53. Antúnez C., Fernández T., Blanca-Lopez N., et al. IgE antibodies to betalactams: relationship between the triggering hapten and the specificity of the immune response. Allergy 61 (2006) 940-946
54. Blanca M., Torres M.J., García J.J., et al. Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol 103 (1999) 918-924
55. Fernández T.D., Torres M.J., Blanca-López N., et al. Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins. Allergy 64 (2009) 242-248
56. Pichler W.J., Schnyder B., Zanni M., et al. Role of T cells in drug allergies. Allergy 53 (1998) 225-232
57. Pichler W.J. Delayed drug hypersensitivity reactions. Ann Intern Med 39 (2003) 683-693
58. Rozieres A., Vocanson M., Saïd B.B., et al. Role of T cells in nonimmediate allergic drug reactions. Curr Opin Allergy Clin Immunol 9 (2009) 305-310
59. Torres M.J., Sanchez-Sabate E., Alvarez J., et al. Skin test evaluation in non-immediate allergic reactions to penicillins. Allergy 59 (2004) 219-224
60. Carey M.A., and van Pelt F.N. Immunochemical detection of flucloxacillin adducts formation in livers of treated rats. Toxicology 216 (2005) 41-48
61. Blanca M., Romano A., Torres M.J., et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 64 (2009) 183-193
62. Torres M.J., Blanca M., de Weck A., et al. Diagnosis of immediate allergic reactions to betalactam antibiotics. Allergy 58 (2003) 854-863
63. Brockow K., Romano A., Blanca M., et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57 (2002) 45-51
64. Blanca M., Mayorga C., Perez E., et al. Determination of IgE antibodies to the benzylpenicilloyl determinant. A comparison between poly-L-lysine and human serum albumin as carriers. J Immunol Methods 153 (1992) 99-105
65. Garcia J.J., Blanca M., Moreno F., et al. Determination of IgE antibodies to the benzylpenicilloyl determinant: a comparison of the sensitivity and specificity of three radio allergo sorbent test methods. J Clin Lab Anal 11 (1997) 251-257
66. Blanca M., Mayorga C., Torres M.J., et al. Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy 56 (2001) 862-870
67. Torres M.J., Padial A., Mayorga C., et al. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clin Exp Allergy 34 (2004) 1768-1775
68. Sanz M.L., Gamboa P.M., Antepara I., et al. Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 32 (2002) 277-286
69. Torres M.J., Mayorga C., Cornejo-García J.A., et al. IgE antibodies to penicillin in skin test negative patients. Allergy 57 (2002) 965
70. Bousquet P.J., Pipet A., Bousquet-Rouanet L., et al. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 38 (2008) 185-190
71. Torres M.J., Romano A., Mayorga C., et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 56 (2001) 850-856
72. Romano A., Blanca M., Torres M.J., et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 59 (2004) 1153-1160
73. Nyfeler B., and Pichler W.J. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 27 (1997) 175-181
74. Luque I., Leyva L., Torres M.J., et al. In vitro T lymphocyte responses to betalactam drugs in immediate and nonimmediate allergic reactions. Allergy 56 (2001) 611-618
75. Romano A., Gueant-Rodriguez R.M., Viola M., et al. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 141 (2004) 16-22
76. Miranda A., Blanca M., Vega J.M., et al. Cross-reactivity between a penicillin and a cephalosporin with the same side chain. J Allergy Clin Immunol 98 (1996) 671-677
77. Romano A., Viola M., Gueant-Rodriguez R.M., et al. Imipenem in patients with immediate hypersensitivity to penicillins. N Engl J Med 354 (2006) 2835-2837
78. Vega J.M., Blanca M., Garci{dotless}a J.J., et al. Tolerance to aztreonam in patients allergic to beta-lactam antibiotics. Allergy 46 (1991) 196-202
79. Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am 29 (2009) 585-606